Feasibility assessment of global standard chemoradiotherapy followed by surgery in patients with esophageal cancer.

chemoradiotherapy cisplatin esophageal cancer esophagectomy fluorouracil

Journal

Molecular and clinical oncology
ISSN: 2049-9469
Titre abrégé: Mol Clin Oncol
Pays: England
ID NLM: 101613422

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 23 11 2022
accepted: 15 02 2023
entrez: 17 3 2023
pubmed: 18 3 2023
medline: 18 3 2023
Statut: epublish

Résumé

The present study aimed to assess the feasibility of global standard chemoradiotherapy (CRT) followed by surgery in patients with esophageal cancer. A prospective study was conducted at Nagoya University Hospital (Nagoya, Japan) to evaluate global standard CRT followed by surgery in patients with esophageal cancer. The CRT regimen consisted of 75 mg/m

Identifiants

pubmed: 36925745
doi: 10.3892/mco.2023.2630
pii: MCO-18-4-02630
pmc: PMC10011946
doi:

Types de publication

Journal Article

Langues

eng

Pagination

34

Informations de copyright

Copyright: © Liang et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

Ann Surg. 2021 Dec 1;274(6):e465-e472
pubmed: 33065643
Ann Surg Oncol. 2020 May;27(5):1510-1517
pubmed: 31820213
Int J Clin Oncol. 2016 Feb;21(1):88-94
pubmed: 26178368
Gastroenterology. 2021 Dec;161(6):1878-1886.e2
pubmed: 34389340
Nephron. 1976;16(1):31-41
pubmed: 1244564
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Lancet Oncol. 2015 Sep;16(9):1090-1098
pubmed: 26254683
Ann Surg Oncol. 2012 Jan;19(1):68-74
pubmed: 21879261
J Clin Oncol. 2002 Mar 1;20(5):1167-74
pubmed: 11870157
N Engl J Med. 1992 Jun 11;326(24):1593-8
pubmed: 1584260
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
Esophagus. 2017;14(1):1-36
pubmed: 28111535
Jpn J Clin Oncol. 2004 Oct;34(10):615-9
pubmed: 15591460
Int J Radiat Oncol Biol Phys. 2022 Nov 1;114(3):454-462
pubmed: 35932949
Gastroenterology. 2019 Aug;157(2):382-390.e3
pubmed: 31014996
Ann Oncol. 2022 Oct;33(10):992-1004
pubmed: 35914638

Auteurs

Yao Liang (Y)

Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Aichi 466-8560, Japan.

Osamu Maeda (O)

Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Aichi 466-8560, Japan.

Kazushi Miyata (K)

Division of Surgical Oncology, Department of Surgery, Nagoya, Aichi 466-8550, Japan.

Mitsuro Kanda (M)

Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.

Dai Shimizu (D)

Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.

Shizuki Sugita (S)

Division of Surgical Oncology, Department of Surgery, Nagoya, Aichi 466-8550, Japan.

Tohru Okada (T)

Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.

Junji Ito (J)

Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.

Mariko Kawamura (M)

Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.

Shunichi Ishihara (S)

Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.

Masahiro Nakatochi (M)

Public Health Informatics Unit, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Aichi 461-8673, Japan.

Masahiko Ando (M)

Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Aichi 466-8560, Japan.

Yasuhiro Kodera (Y)

Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.

Yuichi Ando (Y)

Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Aichi 466-8560, Japan.

Classifications MeSH